For U.S. audience only
For [insert Country] audience only
  • Privacy Policy
  • Terms of Use
  • Contact Us
  • Home
  • More Information for Patients
  • More Information for Health Care Providers
  • Find Out More and Enroll
For U.S. audience only
For [insert Country] audience only
  • Privacy Policy
  • Terms of Use
  • Contact Us
  • Home
  • More Information for Patients
  • More Information for Health Care Providers
  • Find Out More and Enroll

Please see the full Prescribing Information for VYVGART and the full Prescribing Information for VYVGART HYTRULO.

For more information about the study, please visit: https://catalogues.ema.europa.eu/node/3908/

MED-US-VYV-2400025 GLOBAL: V2 06/2025
©2025 argenx BV. All rights reserved.

  • Home
  • Privacy Policy
  • Terms of Use
  • Contact Us

©2025 argenx BV. All rights reserved.
VYVGART is a registered trademark of argenx